| Application number | Title of the application | Filing Date | Status |
|---|
Array
(
[id] => 6801094
[patent_doc_number] => 20030096259
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-05-22
[patent_title] => 'In vitro method for disassembly/reassembly of papillomavirus virus-like particles (VLPs), homogeneous VLP and capsomere compositions produced by said methods; use thereof as vehicle for improved purification, and delivery of active agents'
[patent_app_type] => new
[patent_app_number] => 10/138739
[patent_app_country] => US
[patent_app_date] => 2002-05-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 18309
[patent_no_of_claims] => 54
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 74
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0096/20030096259.pdf
[firstpage_image] =>[orig_patent_app_number] => 10138739
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/138739 | In vitro method for disassembly/reassembly of papillomavirus virus-like particles (VLPs), homogeneous VLP and capsomere compositions produced by said methods; use thereof as vehicle for improved purification, and delivery of active agents | May 5, 2002 | Abandoned |
Array
(
[id] => 7148191
[patent_doc_number] => 20040170644
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-09-02
[patent_title] => 'Mixture of peptides derived from e6 and/or e7 papillomavirus proteins and uses thereof'
[patent_app_type] => new
[patent_app_number] => 10/476570
[patent_app_country] => US
[patent_app_date] => 2004-04-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 11407
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0170/20040170644.pdf
[firstpage_image] =>[orig_patent_app_number] => 10476570
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/476570 | Mixture of peptides derived from E6 and/or E7 papillomavirus proteins and uses thereof | May 2, 2002 | Issued |
Array
(
[id] => 1132573
[patent_doc_number] => 06783763
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2004-08-31
[patent_title] => 'Polyepitopic proteinic fragments of the E6 and E7 HPV proteins, production and use thereof in vaccines'
[patent_app_type] => B1
[patent_app_number] => 09/980523
[patent_app_country] => US
[patent_app_date] => 2002-04-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 10577
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/783/06783763.pdf
[firstpage_image] =>[orig_patent_app_number] => 09980523
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/980523 | Polyepitopic proteinic fragments of the E6 and E7 HPV proteins, production and use thereof in vaccines | Apr 28, 2002 | Issued |
Array
(
[id] => 7033127
[patent_doc_number] => 20050031636
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-02-10
[patent_title] => 'Papilloma virus capsomere vaccine formulations and methods of use'
[patent_app_type] => utility
[patent_app_number] => 10/042526
[patent_app_country] => US
[patent_app_date] => 2002-04-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7623
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0031/20050031636.pdf
[firstpage_image] =>[orig_patent_app_number] => 10042526
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/042526 | Papilloma virus capsomere vaccine formulations and methods of use | Apr 28, 2002 | Abandoned |
Array
(
[id] => 6724586
[patent_doc_number] => 20030206898
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-11-06
[patent_title] => 'Use of anti-TNFalpha antibodies and another drug'
[patent_app_type] => new
[patent_app_number] => 10/133715
[patent_app_country] => US
[patent_app_date] => 2002-04-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19344
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0206/20030206898.pdf
[firstpage_image] =>[orig_patent_app_number] => 10133715
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/133715 | Use of anti-TNFalpha antibodies and another drug | Apr 25, 2002 | Abandoned |
Array
(
[id] => 6847029
[patent_doc_number] => 20030166196
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-09-04
[patent_title] => 'Fusion proteins and polynucleotides encoding gelonin sequences'
[patent_app_type] => new
[patent_app_number] => 10/127890
[patent_app_country] => US
[patent_app_date] => 2002-04-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 42207
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0166/20030166196.pdf
[firstpage_image] =>[orig_patent_app_number] => 10127890
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/127890 | Fusion proteins and polynucleotides encoding gelonin sequences | Apr 22, 2002 | Abandoned |
Array
(
[id] => 6778241
[patent_doc_number] => 20030049322
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-03-13
[patent_title] => 'Aqueous-based pharmaceutical composition'
[patent_app_type] => new
[patent_app_number] => 10/128154
[patent_app_country] => US
[patent_app_date] => 2002-04-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 6911
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 107
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0049/20030049322.pdf
[firstpage_image] =>[orig_patent_app_number] => 10128154
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/128154 | Aqueous-based pharmaceutical composition | Apr 22, 2002 | Issued |
| 09/980417 | Test system for in-vitro detection of an antigen-specific immune response | Apr 11, 2002 | Abandoned |
Array
(
[id] => 6817369
[patent_doc_number] => 20030068327
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-04-10
[patent_title] => 'Compositions and methods for the diagnosis and threatment of herpes simplex virus infection'
[patent_app_type] => new
[patent_app_number] => 10/121988
[patent_app_country] => US
[patent_app_date] => 2002-04-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 47830
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0068/20030068327.pdf
[firstpage_image] =>[orig_patent_app_number] => 10121988
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/121988 | Compositions and methods for the diagnosis and threatment of herpes simplex virus infection | Apr 10, 2002 | Abandoned |
Array
(
[id] => 1068464
[patent_doc_number] => 06844001
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2005-01-18
[patent_title] => 'Adjuvants and copolymer compositions'
[patent_app_type] => utility
[patent_app_number] => 10/115332
[patent_app_country] => US
[patent_app_date] => 2002-04-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 32
[patent_figures_cnt] => 52
[patent_no_of_words] => 13743
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 65
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/844/06844001.pdf
[firstpage_image] =>[orig_patent_app_number] => 10115332
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/115332 | Adjuvants and copolymer compositions | Apr 1, 2002 | Issued |
Array
(
[id] => 6787203
[patent_doc_number] => 20030138442
[patent_country] => US
[patent_kind] => A9
[patent_issue_date] => 2003-07-24
[patent_title] => 'Proteins encoded by polynucleic acids of porcine reproductive and respiratory syndrome virus (PRRSV)'
[patent_app_type] => corrected
[patent_app_number] => 10/104019
[patent_app_country] => US
[patent_app_date] => 2002-03-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 29
[patent_figures_cnt] => 29
[patent_no_of_words] => 28684
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A9/0138/20030138442.pdf
[firstpage_image] =>[orig_patent_app_number] => 10104019
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/104019 | Proteins encoded by polynucleic acids of porcine reproductive and respiratory syndrome virus (PRRSV) | Mar 24, 2002 | Issued |
Array
(
[id] => 6787203
[patent_doc_number] => 20030138442
[patent_country] => US
[patent_kind] => A9
[patent_issue_date] => 2003-07-24
[patent_title] => 'Proteins encoded by polynucleic acids of porcine reproductive and respiratory syndrome virus (PRRSV)'
[patent_app_type] => corrected
[patent_app_number] => 10/104019
[patent_app_country] => US
[patent_app_date] => 2002-03-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 29
[patent_figures_cnt] => 29
[patent_no_of_words] => 28684
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A9/0138/20030138442.pdf
[firstpage_image] =>[orig_patent_app_number] => 10104019
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/104019 | Proteins encoded by polynucleic acids of porcine reproductive and respiratory syndrome virus (PRRSV) | Mar 24, 2002 | Issued |
Array
(
[id] => 516976
[patent_doc_number] => 07189513
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-03-13
[patent_title] => 'Human papilloma virus immunoreactive peptides'
[patent_app_type] => utility
[patent_app_number] => 10/472661
[patent_app_country] => US
[patent_app_date] => 2002-03-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 19124
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 125
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/189/07189513.pdf
[firstpage_image] =>[orig_patent_app_number] => 10472661
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/472661 | Human papilloma virus immunoreactive peptides | Mar 21, 2002 | Issued |
Array
(
[id] => 1238671
[patent_doc_number] => 06685947
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2004-02-03
[patent_title] => 'T helper cell epitopes'
[patent_app_type] => B1
[patent_app_number] => 09/890650
[patent_app_country] => US
[patent_app_date] => 2002-03-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 9532
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 42
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/685/06685947.pdf
[firstpage_image] =>[orig_patent_app_number] => 09890650
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/890650 | T helper cell epitopes | Mar 21, 2002 | Issued |
Array
(
[id] => 7151857
[patent_doc_number] => 20040171806
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-09-02
[patent_title] => 'Modified hpv e6 and e7 genes and proteins useful for vaccination'
[patent_app_type] => new
[patent_app_number] => 10/472724
[patent_app_country] => US
[patent_app_date] => 2004-01-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 8080
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0171/20040171806.pdf
[firstpage_image] =>[orig_patent_app_number] => 10472724
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/472724 | Modified HPV E6 and E7 genes and proteins useful for vaccination | Mar 21, 2002 | Issued |
Array
(
[id] => 5844398
[patent_doc_number] => 20020132336
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-09-19
[patent_title] => 'Replication-defective recombinant AAV virions'
[patent_app_type] => new
[patent_app_number] => 10/099252
[patent_app_country] => US
[patent_app_date] => 2002-03-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7343
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 139
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0132/20020132336.pdf
[firstpage_image] =>[orig_patent_app_number] => 10099252
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/099252 | Replication-defective recombinant AAV virions | Mar 14, 2002 | Abandoned |
Array
(
[id] => 1292596
[patent_doc_number] => RE038252
[patent_country] => US
[patent_kind] => E1
[patent_issue_date] => 2003-09-16
[patent_title] => 'Corn cDNA encoding southern leaf blight resistance'
[patent_app_type] => E1
[patent_app_number] => 10/095946
[patent_app_country] => US
[patent_app_date] => 2002-03-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 3
[patent_no_of_words] => 16560
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/RE/038/RE038252.pdf
[firstpage_image] =>[orig_patent_app_number] => 10095946
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/095946 | Corn cDNA encoding southern leaf blight resistance | Mar 10, 2002 | Issued |
Array
(
[id] => 1317998
[patent_doc_number] => 06605465
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-08-12
[patent_title] => 'Methods for avoiding maternal immunity'
[patent_app_type] => B1
[patent_app_number] => 10/094440
[patent_app_country] => US
[patent_app_date] => 2002-03-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 83
[patent_figures_cnt] => 42
[patent_no_of_words] => 34544
[patent_no_of_claims] => 39
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/605/06605465.pdf
[firstpage_image] =>[orig_patent_app_number] => 10094440
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/094440 | Methods for avoiding maternal immunity | Mar 7, 2002 | Issued |
| 10/070285 | Equine herpes virus temperature sensitive mutant and live vaccine thereof | Mar 4, 2002 | Abandoned |
Array
(
[id] => 1304521
[patent_doc_number] => 06616930
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2003-09-09
[patent_title] => 'Peptide fragment of respiratory syncytial virus protein G, immunogenic agent, pharmaceutical composition containing it and preparation method'
[patent_app_type] => B2
[patent_app_number] => 10/091257
[patent_app_country] => US
[patent_app_date] => 2002-03-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 13301
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 73
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/616/06616930.pdf
[firstpage_image] =>[orig_patent_app_number] => 10091257
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/091257 | Peptide fragment of respiratory syncytial virus protein G, immunogenic agent, pharmaceutical composition containing it and preparation method | Mar 4, 2002 | Issued |